Literature DB >> 21949018

Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells.

Jine Yang1, Xiaolin Hu, Mary Zimmerman, Christina M Torres, Dafeng Yang, Sylvia B Smith, Kebin Liu.   

Abstract

A prominent phenotype of IRF8 knockout (KO) mice is the uncontrolled expansion of immature myeloid cells. The molecular mechanism underlying this myeloproliferative syndrome is still elusive. In this study, we observed that Bax expression level is low in bone marrow preginitor cells and increases dramatically in primary myeloid cells in wt mice. In contrast, Bax expression level remained at a low level in primarymyeloid cells in IRF8 KO mice. However, in vitro IRF8 KO bone marrow-differentiated myeloid cells expressed Bax at a level as high as that in wild type myeloid cells. Furthermore, we demonstrated that IRF8 specifically binds to the Bax promoter region in primary myeloid cells. Functional analysis indicated that IRF8 deficiency results in increased resistance of the primary myeloid cells to Fas-mediated apoptosis. Our findings show that IRF8 directly regulates Bax transcription in vivo, but not in vitro during myeloid cell lineage differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949018      PMCID: PMC3197864          DOI: 10.4049/jimmunol.1101034

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.

Authors:  R M Siegel; F K Chan; H J Chun; M J Lenardo
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

2.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.

Authors:  T Tamura; T Nagamura-Inoue; Z Shmeltzer; T Kuwata; K Ozato
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

3.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

4.  IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia.

Authors:  Xiaolin Hu; Dafeng Yang; Mary Zimmerman; Feiyan Liu; Jine Yang; Swati Kannan; Andreas Burchert; Zdzislaw Szulc; Alicja Bielawska; Keiko Ozato; Kapil Bhalla; Kebin Liu
Journal:  Cancer Res       Date:  2011-04-12       Impact factor: 12.701

5.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

6.  IRF8 and IRF3 cooperatively regulate rapid interferon-β induction in human blood monocytes.

Authors:  Peng Li; Joyce Jing-Yi Wong; Calvin Sum; Wei-Xiang Sin; Kok-Quan Ng; Mickey B C Koh; Keh-Chuang Chin
Journal:  Blood       Date:  2011-01-12       Impact factor: 22.113

7.  Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.

Authors:  Pratima Sinha; Olesya Chornoguz; Virginia K Clements; Konstantin A Artemenko; Roman A Zubarev; Suzanne Ostrand-Rosenberg
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

8.  Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2.

Authors:  Andreas Burchert; Dali Cai; Lorenz C Hofbauer; Magnus K R Samuelsson; Emily P Slater; Justus Duyster; Markus Ritter; Andreas Hochhaus; Rolf Müller; Martin Eilers; Manuel Schmidt; Andreas Neubauer
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

9.  IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.

Authors:  Mary Zimmerman; Dafeng Yang; Xiaolin Hu; Feiyan Liu; Nagendra Singh; Darren Browning; Vadivel Ganapathy; Phillip Chandler; Divaker Choubey; Scott I Abrams; Kebin Liu
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

10.  IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage.

Authors:  Hideki Tsujimura; Tokiko Nagamura-Inoue; Tomohiko Tamura; Keiko Ozato
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

View more
  16 in total

1.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

Review 2.  The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases.

Authors:  Xiao-Jing Zhang; Ding-Sheng Jiang; Hongliang Li
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

3.  Pak2 regulates myeloid-derived suppressor cell development in mice.

Authors:  Yi Zeng; Seongmin Hahn; Jessica Stokes; Emely A Hoffman; Monika Schmelz; Maria Proytcheva; Jonathan Chernoff; Emmanuel Katsanis
Journal:  Blood Adv       Date:  2017-10-10

4.  IFNγ Induces DNA Methylation-Silenced GPR109A Expression via pSTAT1/p300 and H3K18 Acetylation in Colon Cancer.

Authors:  Kankana Bardhan; Amy V Paschall; Dafeng Yang; May R Chen; Priscilla S Simon; Yangzom D Bhutia; Pamela M Martin; Muthusamy Thangaraju; Darren D Browning; Vadivel Ganapathy; Christopher M Heaton; Keni Gu; Jeffrey R Lee; Kebin Liu
Journal:  Cancer Immunol Res       Date:  2015-03-03       Impact factor: 11.151

5.  A role for IRF8 in B cell anergy.

Authors:  Simanta Pathak; Shibin Ma; Vipul Shukla; Runqing Lu
Journal:  J Immunol       Date:  2013-11-11       Impact factor: 5.422

6.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

7.  A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway Compounds.

Authors:  Fathima Shazna Thowfeik; Safnas F AbdulSalam; Mark Wunderlich; Michael Wyder; Kenneth D Greis; Ana L Kadekaro; James C Mulloy; Edward J Merino
Journal:  Chembiochem       Date:  2015-11-02       Impact factor: 3.164

8.  DNA methylation protects against cisplatin-induced kidney injury by regulating specific genes, including interferon regulatory factor 8.

Authors:  Chunyuan Guo; Lirong Pei; Xiao Xiao; Qingqing Wei; Jian-Kang Chen; Han-Fei Ding; Shuang Huang; Guoping Fan; Huidong Shi; Zheng Dong
Journal:  Kidney Int       Date:  2017-07-12       Impact factor: 10.612

Review 9.  Developmental pathways of myeloid-derived suppressor cells in neoplasia.

Authors:  Scott I Abrams
Journal:  Cell Immunol       Date:  2020-12-16       Impact factor: 4.868

10.  Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity.

Authors:  Debarati Banik; A Nazmul H Khan; Even Walseng; Brahm H Segal; Scott I Abrams
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.